Company Research Report

Company Overview

Name

Parexel International Corporation

Mission

At Parexel, the mission is to speed life-changing medicines to patients by designing solutions "With Heart," emphasizing passion, commitment to problem-solving, and a focus on the patient experience to advance clinical trials.

Founded

Founded year not explicitly mentioned in the provided data; however, references indicate a history of over 40 years.

Founders

No information is available.

Key People

Andreas Lysandropoulos, M.D., Ph.D. - Senior Vice President, Global Neuroscience Therapeutic Area Head

Antal János, M.D., M.B.A. - Vice President

Karla Kanis, M.D. - Vice President

Mohit Verma, M.D. - Global Section Head

Headquarters

2520 Meridian Parkway, Durham, NC 27713, USA

Number of Employees

Parexel employs more than 21,000 global professionals.

Revenue

No information is available.

Known For

Parexel is recognized for being one of the world's largest clinical research organizations (CROs), providing a full range of Phase I to IV clinical development services. They specialize in accelerating clinical trials and ensuring accessibility and inclusion in research.

Products

Product Offerings

Therapeutic Areas:

Neuroscience

Oncology

Rare Diseases

Inflammation & Immunology

Cell & Gene Therapy

High-Level Description

Parexel offers integrated solutions across all phases of clinical development to help biopharmaceutical companies manage and execute clinical trials with a patient-first approach.

Key Features

Discovery:

Portfolio management & asset valuation

Early evidence review

Early Stage:

Phase I clinical trials

Biomarker and genomic medicine strategy

Late Stage:

Phase IIb-IV clinical trials

Real-world evidence

Post Approval:

Global regulatory submissions

Market access strategy

Services

Patient engagement strategy and enrollment solutions

Regulatory and market access strategy

Integrated development strategy and planning

Clinical trial supply and logistics

Medical communications

Recent Developments

Parexel continues to lead the industry in trial inclusivity and accessibility, significantly impacting clinical trial design with a focus on diverse and accessible patient involvement.

They have received multiple awards, including the 2024 ViE Best Contract Research Organization and 2023 Scrip Award for Best CRO.

New Products Launched

No specific new product launches are detailed.

New Features Added to Existing Products

Parexel has been recognized for implementing innovative trial designs, including the use of advanced modeling and simulation to predict drug effects.

New Partnerships

No information is available.

Note: This report is based solely on the provided data without any additional commentary or sources, focusing on the direct information available from the text.